Skip to main content

Table 1 Characteristics of patients with rheumatoid arthritis

From: Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study

Characteristics

Overall

 

N = 517

Sex (female)

429 (83.0)

Age, years

62.5 (61.4–63.6)

Disease duration, months

160.9 (148.8–173.1)

Stage

 

I

114 (22.1)

II

125 (24.2)

III

96 (18.6)

IV

180 (35.0)

Disease activity

 

DAS28-CRP

1.91 (1.83–1.98)

DAS28-CRP remission†

360 (78.9)

Low disease activity†

57 (12.5)

Moderate disease activity†

37 (8.1)

High disease activity†

2 (0.5)

TJC

0.82 (0.69–0.96)

SJC

0.80 (0.67–0.93)

PtGA

29.1 (27.0–31.2)

CRP

0.40 (0.33–0.47)

HAQ-DI

0.75 (0.68–0.82)

HAQ-DI remission

252 (51.3)

Pain VAS

27.6 (25.4–29.9)

Treatment

 

Biological DMARD

187 (36.2)

Methotrexate

345 (66.7)

Steroid

159 (30.8)

Anxiety and depression

 

Anxiety

91 (17.6)

Depression

143 (27.7)

  1. Data are presented as mean (95% confidence interval) or number (%). Remission: DAS28-CRP < 2.6; VAS range: 0 (no pain) to 100 (maximum pain); Anxiety: HADS-A score ≥ 8, Depression: HADS-D score ≥ 8
  2. DAS28 Disease Activity Score in 28 joints, TJC tender joint count, SJC swollen joint count, PtGA patient global assessment, CRP C-reactive protein, HAQ-DI Health Assessment Questionnaire Disability Index, HADS-A Hospital Anxiety and Depression Scale-Anxiety subscale, HADS-D Hospital Anxiety and Depression Scale-Depression subscale, DMARD disease-modifying anti-rheumatic drug, VAS Visual Analogue Scale
  3. †N = 456 for DAS28-CRP remission owing to 61 missing responses